| Catalog No. | DS856058 |
|---|
| Sample type | Plasma, Serum |
|---|
| Sensitivity | 715.94 ng/mL. |
|---|
| Range | 937.5 - 15,000 ng/mL |
|---|
| Accession | Q16552 |
|---|
| Applications | ELISA |
|---|
| Detection method | Colorimetric |
|---|
| Assay type | Quantitative |
|---|
| Recovery | 80-120% |
|---|
| Shipping | 2-8 ℃ |
|---|
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃. |
|---|
| Specifications | Secukinumab |
|---|
| Alternate Names | AIN457, CAS: 1229022-83-6 |
|---|
| Background | Secukinumab (Cosentyx) is a fully human IgG1/κ-class monoclonal antibody (mAb) composed of 215 light chain amino acids and 457 heavy chain amino acids. It was discovered and developed by Novartis with the developmental name AIN457, for the treatment of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. It is produced in Chinese Hamster Ovary (CHO) cells using recombinant DNA technology. |
|---|
| Note | For Research Use Only. |
|---|
